Mitchell H. Finer, Ph.D. c/o MPM Capital Cambridge, MA 02142 Re: Transition to Board Chairman Dear Dr. Finer:Oncorus, Inc. • March 9th, 2022 • Pharmaceutical preparations
This letter memorializes the understanding between you, Mitchell H. Finer, Ph.D., and Oncorus, Inc. (the “Company”) as of the date hereof (the “Effective Date”) with respect to your transition from the role of Executive Chairman of the Company’s board of directors (the “Board”) to non-executive Chairman of the Board.
LICENSE AGREEMENTLicense Agreement • March 9th, 2022 • Oncorus, Inc. • Pharmaceutical preparations • New York
SECOND AMENDMENT TO LEASE (Innovation Park)Lease • March 9th, 2022 • Oncorus, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO LEASE (“Second Amendment”) is made and entered into as of the 17th day of November, 2021, by and between IQHQ‑4 CORPORATE, LLC, a Delaware limited liability company (“Landlord”) and ONCORUS, INC., a Delaware corporation (“Tenant”).
